HK1026613A1 - Aqueous immunologic adjuvant compositions of monophosphoryl lipid a. - Google Patents
Aqueous immunologic adjuvant compositions of monophosphoryl lipid a.Info
- Publication number
- HK1026613A1 HK1026613A1 HK00104464A HK00104464A HK1026613A1 HK 1026613 A1 HK1026613 A1 HK 1026613A1 HK 00104464 A HK00104464 A HK 00104464A HK 00104464 A HK00104464 A HK 00104464A HK 1026613 A1 HK1026613 A1 HK 1026613A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- surfactant
- lipid
- derivative
- attenuated
- monophosphoryl lipid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83107397A | 1997-04-01 | 1997-04-01 | |
PCT/US1998/006528 WO1998043670A2 (en) | 1997-04-01 | 1998-04-01 | Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1026613A1 true HK1026613A1 (en) | 2000-12-22 |
Family
ID=25258229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00104464A HK1026613A1 (en) | 1997-04-01 | 2000-07-19 | Aqueous immunologic adjuvant compositions of monophosphoryl lipid a. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0971739B1 (xx) |
JP (1) | JP5019494B2 (xx) |
KR (1) | KR100603884B1 (xx) |
CN (2) | CN1259052A (xx) |
AT (1) | ATE278419T1 (xx) |
AU (1) | AU743114B2 (xx) |
BR (1) | BR9811262A (xx) |
CA (1) | CA2284586C (xx) |
DE (1) | DE69826842T2 (xx) |
ES (1) | ES2227825T3 (xx) |
HK (1) | HK1026613A1 (xx) |
HU (1) | HUP0001403A3 (xx) |
IL (2) | IL132126A0 (xx) |
NO (1) | NO994760L (xx) |
NZ (1) | NZ338101A (xx) |
PL (1) | PL190237B1 (xx) |
PT (1) | PT971739E (xx) |
TR (1) | TR199902437T2 (xx) |
WO (1) | WO1998043670A2 (xx) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6491919B2 (en) | 1997-04-01 | 2002-12-10 | Corixa Corporation | Aqueous immunologic adjuvant compostions of monophosphoryl lipid A |
GB9706957D0 (en) | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
GB0000891D0 (en) * | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
EP2266603B1 (en) | 2000-10-18 | 2012-09-12 | GlaxoSmithKline Biologicals S.A. | Tumour vaccines |
EP1361890B1 (en) | 2001-02-23 | 2011-03-30 | GlaxoSmithKline Biologicals s.a. | Influenza vaccine formulations for intradermal delivery |
US20030031684A1 (en) | 2001-03-30 | 2003-02-13 | Corixa Corporation | Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA) |
GB0109297D0 (en) | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
US20100221284A1 (en) | 2001-05-30 | 2010-09-02 | Saech-Sisches Serumwerk Dresden | Novel vaccine composition |
TWI228420B (en) | 2001-05-30 | 2005-03-01 | Smithkline Beecham Pharma Gmbh | Novel vaccine composition |
GB0321615D0 (en) | 2003-09-15 | 2003-10-15 | Glaxo Group Ltd | Improvements in vaccination |
PT1828378E (pt) * | 2004-12-17 | 2014-10-10 | Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheid Welzijn En Sport | Deacilação de lps em bactérias de gram negativo |
GB0503337D0 (en) | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
GB0504436D0 (en) | 2005-03-03 | 2005-04-06 | Glaxosmithkline Biolog Sa | Vaccine |
BRPI0611347A2 (pt) | 2005-04-29 | 2010-08-31 | Glaxosmithline Biolog S A | composicão farmacêutica, usos de uma proteìna de fusão mtb72f ou um fragmento imunogênico da mesma, e, de um ácido nucléico |
NZ565512A (en) * | 2005-08-02 | 2011-08-26 | Novartis Vaccines & Diagnostic | Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
TWI457133B (zh) * | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
US8018440B2 (en) | 2005-12-30 | 2011-09-13 | Microsoft Corporation | Unintentional touch rejection |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
EP2486938B1 (en) | 2006-09-26 | 2018-05-09 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
US8836648B2 (en) | 2009-05-27 | 2014-09-16 | Microsoft Corporation | Touch pull-in gesture |
CA2764374C (en) | 2009-06-05 | 2019-11-19 | Infectious Disease Research Institute | Synthetic glucopyranosyl lipid adjuvants |
FR2954703B1 (fr) | 2009-12-28 | 2013-12-13 | Chu Nantes | Agonistes des recepteurs tlr 4 et 9 pour prevenir les complications septiques de l'immunodepression post-traumatique chez les patients hospitalises pour traumatismes severes |
US8261213B2 (en) | 2010-01-28 | 2012-09-04 | Microsoft Corporation | Brush, carbon-copy, and fill gestures |
US9411504B2 (en) | 2010-01-28 | 2016-08-09 | Microsoft Technology Licensing, Llc | Copy and staple gestures |
US9519356B2 (en) | 2010-02-04 | 2016-12-13 | Microsoft Technology Licensing, Llc | Link gestures |
US9367205B2 (en) | 2010-02-19 | 2016-06-14 | Microsoft Technolgoy Licensing, Llc | Radial menus with bezel gestures |
US9310994B2 (en) | 2010-02-19 | 2016-04-12 | Microsoft Technology Licensing, Llc | Use of bezel as an input mechanism |
US8799827B2 (en) | 2010-02-19 | 2014-08-05 | Microsoft Corporation | Page manipulations using on and off-screen gestures |
US9075522B2 (en) | 2010-02-25 | 2015-07-07 | Microsoft Technology Licensing, Llc | Multi-screen bookmark hold gesture |
US8707174B2 (en) | 2010-02-25 | 2014-04-22 | Microsoft Corporation | Multi-screen hold and page-flip gesture |
US8751970B2 (en) | 2010-02-25 | 2014-06-10 | Microsoft Corporation | Multi-screen synchronous slide gesture |
US9454304B2 (en) | 2010-02-25 | 2016-09-27 | Microsoft Technology Licensing, Llc | Multi-screen dual tap gesture |
US8612874B2 (en) | 2010-12-23 | 2013-12-17 | Microsoft Corporation | Presenting an application change through a tile |
US8689123B2 (en) | 2010-12-23 | 2014-04-01 | Microsoft Corporation | Application reporting in an application-selectable user interface |
US9423951B2 (en) | 2010-12-31 | 2016-08-23 | Microsoft Technology Licensing, Llc | Content-based snap point |
US9383917B2 (en) | 2011-03-28 | 2016-07-05 | Microsoft Technology Licensing, Llc | Predictive tiling |
GB201106357D0 (en) | 2011-04-14 | 2011-06-01 | Pessi Antonello | Composition and uses thereof |
JP6054942B2 (ja) | 2011-04-08 | 2016-12-27 | イミューン デザイン コーポレイション | 免疫原性組成物、ならびに体液性および細胞性免疫応答を誘発するための該組成物の使用方法 |
US9658766B2 (en) | 2011-05-27 | 2017-05-23 | Microsoft Technology Licensing, Llc | Edge gesture |
US9158445B2 (en) | 2011-05-27 | 2015-10-13 | Microsoft Technology Licensing, Llc | Managing an immersive interface in a multi-application immersive environment |
US9104440B2 (en) | 2011-05-27 | 2015-08-11 | Microsoft Technology Licensing, Llc | Multi-application environment |
US9104307B2 (en) | 2011-05-27 | 2015-08-11 | Microsoft Technology Licensing, Llc | Multi-application environment |
US9557909B2 (en) | 2011-09-09 | 2017-01-31 | Microsoft Technology Licensing, Llc | Semantic zoom linguistic helpers |
US9146670B2 (en) | 2011-09-10 | 2015-09-29 | Microsoft Technology Licensing, Llc | Progressively indicating new content in an application-selectable user interface |
US9244802B2 (en) | 2011-09-10 | 2016-01-26 | Microsoft Technology Licensing, Llc | Resource user interface |
EP2755684A1 (en) | 2011-09-12 | 2014-07-23 | Jonathan Norden Weber | Methods and compositions for raising an immune response to hiv |
JP6619648B2 (ja) | 2012-05-16 | 2019-12-11 | イミューン デザイン コーポレイション | Hsv−2のためのワクチン |
EP2666785A1 (en) | 2012-05-23 | 2013-11-27 | Affiris AG | Complement component C5a-based vaccine |
EP2703483A1 (en) | 2012-08-29 | 2014-03-05 | Affiris AG | PCSK9 peptide vaccine |
WO2014043189A1 (en) | 2012-09-14 | 2014-03-20 | The Regents Of The University Of Colorado, A Body Corporate | Conditionally replication deficient herpes viruses and use thereof in vaccines |
US9582122B2 (en) | 2012-11-12 | 2017-02-28 | Microsoft Technology Licensing, Llc | Touch-sensitive bezel techniques |
CN105209047B (zh) | 2013-04-18 | 2020-08-18 | 免疫设计股份有限公司 | 用于癌症治疗的gla单一疗法 |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
US9477337B2 (en) | 2014-03-14 | 2016-10-25 | Microsoft Technology Licensing, Llc | Conductive trace routing for display and bezel sensors |
WO2015144655A1 (en) * | 2014-03-26 | 2015-10-01 | Glaxosmithkline Biologicals S.A. | Immunising against staphylococcus aureus |
JP6820830B2 (ja) | 2014-07-18 | 2021-01-27 | ユニヴァーシティ オブ ワシントン | がんワクチン組成物およびその使用方法 |
EP3138579A1 (en) | 2015-09-05 | 2017-03-08 | Biomay Ag | Fusion protein for use in the treatment of a hepatitis b virus infection |
GB201614799D0 (en) | 2016-09-01 | 2016-10-19 | Glaxosmithkline Biologicals Sa | Compositions |
EP3295956A1 (en) | 2016-09-20 | 2018-03-21 | Biomay Ag | Polypeptide construct comprising fragments of allergens |
CN111315406A (zh) | 2017-09-08 | 2020-06-19 | 传染病研究所 | 包括皂苷的脂质体调配物及其使用方法 |
WO2019175145A1 (en) | 2018-03-12 | 2019-09-19 | Janssen Vaccines & Prevention B.V. | Vaccines against urinary tract infections |
EP3569612A1 (en) | 2018-05-18 | 2019-11-20 | Biomay Ag | Treatment and prevention of house dust mite allergies |
HRP20231026T1 (hr) | 2019-03-18 | 2023-12-08 | Janssen Pharmaceuticals, Inc. | Postupci za proizvodnju biokonjugata polisaharida o-antigena e. coli, njihovi pripravci i postupci njihove primjene |
KR102532707B1 (ko) | 2019-03-18 | 2023-05-12 | 얀센 파마슈티칼즈, 인코포레이티드 | 대장균 o-항원 다당류의 바이오컨쥬게이트, 이의 제조 방법, 및 이의 사용 방법 |
KR20220107166A (ko) | 2019-10-02 | 2022-08-02 | 얀센 백신스 앤드 프리벤션 비.브이. | 스타필로코커스 펩티드 및 사용 방법 |
AU2021208493B2 (en) | 2020-01-16 | 2023-03-30 | Janssen Pharmaceuticals, Inc. | FimH mutant, compositions therewith and use thereof |
IL308201A (en) | 2020-09-17 | 2024-01-01 | Janssen Pharmaceuticals Inc | Multivalent vaccine compositions and uses thereof |
KR20230125842A (ko) | 2021-01-12 | 2023-08-29 | 얀센 파마슈티칼즈, 인코포레이티드 | FimH 돌연변이체, 이를 포함하는 조성물 및 이의 용도 |
BR112023019874A2 (pt) | 2021-04-01 | 2023-11-07 | Janssen Pharmaceuticals Inc | Produção de bioconjugados de e. coli o18 |
CA3219814A1 (en) * | 2021-05-27 | 2022-12-01 | James M. Rolke | Mpla compositions and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4912094B1 (en) * | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
US5068191A (en) * | 1989-08-31 | 1991-11-26 | The Biomembrane Institute | Purified histo-blood group a glycosyltransferase and antibodies thereto |
US5552141A (en) * | 1991-10-30 | 1996-09-03 | Ribi; Hans O. | Polymeric immunological adjuvants |
CZ289476B6 (cs) * | 1993-03-23 | 2002-01-16 | Smithkline Beecham Biologicals (S.A.) | Očkovací přípravek a způsob jeho výroby |
-
1998
- 1998-04-01 WO PCT/US1998/006528 patent/WO1998043670A2/en active IP Right Grant
- 1998-04-01 CA CA2284586A patent/CA2284586C/en not_active Expired - Lifetime
- 1998-04-01 CN CN98804685A patent/CN1259052A/zh active Pending
- 1998-04-01 BR BR9811262-7A patent/BR9811262A/pt not_active Application Discontinuation
- 1998-04-01 IL IL13212698A patent/IL132126A0/xx active IP Right Grant
- 1998-04-01 KR KR1019997008958A patent/KR100603884B1/ko not_active IP Right Cessation
- 1998-04-01 NZ NZ338101A patent/NZ338101A/en unknown
- 1998-04-01 JP JP54200198A patent/JP5019494B2/ja not_active Expired - Lifetime
- 1998-04-01 AT AT98915239T patent/ATE278419T1/de active
- 1998-04-01 ES ES98915239T patent/ES2227825T3/es not_active Expired - Lifetime
- 1998-04-01 AU AU69473/98A patent/AU743114B2/en not_active Ceased
- 1998-04-01 EP EP98915239A patent/EP0971739B1/en not_active Expired - Lifetime
- 1998-04-01 PT PT98915239T patent/PT971739E/pt unknown
- 1998-04-01 TR TR1999/02437T patent/TR199902437T2/xx unknown
- 1998-04-01 PL PL98336698A patent/PL190237B1/pl not_active IP Right Cessation
- 1998-04-01 CN CNB2004100713486A patent/CN1326564C/zh not_active Expired - Fee Related
- 1998-04-01 DE DE69826842T patent/DE69826842T2/de not_active Expired - Lifetime
- 1998-04-01 HU HU0001403A patent/HUP0001403A3/hu unknown
-
1999
- 1999-09-29 IL IL132126A patent/IL132126A/en not_active IP Right Cessation
- 1999-09-30 NO NO994760A patent/NO994760L/no not_active Application Discontinuation
-
2000
- 2000-07-19 HK HK00104464A patent/HK1026613A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO994760L (no) | 1999-11-26 |
PT971739E (pt) | 2004-12-31 |
CA2284586C (en) | 2011-02-08 |
PL190237B1 (pl) | 2005-11-30 |
TR199902437T2 (xx) | 2000-01-21 |
HUP0001403A2 (hu) | 2000-09-28 |
IL132126A0 (en) | 2001-03-19 |
HUP0001403A3 (en) | 2003-05-28 |
JP5019494B2 (ja) | 2012-09-05 |
EP0971739B1 (en) | 2004-10-06 |
KR100603884B1 (ko) | 2006-07-24 |
CN1326564C (zh) | 2007-07-18 |
CN1575815A (zh) | 2005-02-09 |
BR9811262A (pt) | 2000-10-17 |
EP0971739A2 (en) | 2000-01-19 |
WO1998043670A3 (en) | 1998-12-30 |
JP2001526640A (ja) | 2001-12-18 |
CN1259052A (zh) | 2000-07-05 |
AU6947398A (en) | 1998-10-22 |
WO1998043670A2 (en) | 1998-10-08 |
DE69826842T2 (de) | 2005-11-24 |
ES2227825T3 (es) | 2005-04-01 |
NZ338101A (en) | 2002-03-28 |
CA2284586A1 (en) | 1998-10-08 |
PL336698A1 (en) | 2000-07-03 |
KR20010005882A (ko) | 2001-01-15 |
ATE278419T1 (de) | 2004-10-15 |
AU743114B2 (en) | 2002-01-17 |
IL132126A (en) | 2006-10-05 |
NO994760D0 (no) | 1999-09-30 |
DE69826842D1 (de) | 2004-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1026613A1 (en) | Aqueous immunologic adjuvant compositions of monophosphoryl lipid a. | |
WO2000078353A3 (en) | Aqueous immunologic adjuvant compositions of monophosphoryl lipid a | |
US6500453B2 (en) | Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom | |
US20200109160A1 (en) | Lipid a mimics, methods of preparation, and uses thereof | |
ES2039229T3 (es) | Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos. | |
EP0781559B1 (en) | Oil adjuvant vaccine and method for preparing same | |
US4117113A (en) | Immunological preparations | |
JPH0832638B2 (ja) | サブミクロン油滴乳剤を含んで成るアジュバント製剤 | |
GB2124618A (en) | Aliphatic hydroxy amides | |
AP9400683A0 (en) | Vaccines. | |
PE20000574A1 (es) | Articulos, metodos y composiciones para limpiar productos agricolas y proteina animal comestible | |
Blom et al. | Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition | |
ES2148475T3 (es) | Procedimiento para elaborar formulaciones solidas que contienen agentes tensioactivos de oxidos de aminas. | |
KR0178422B1 (ko) | 한탄 바이러스의 펩타이드 항원을 함유하는 리포좀 | |
KR0173366B1 (ko) | B형 간염 바이러스의 펩타이드 항원을 함유하는 리포좀 | |
KR0173365B1 (ko) | C형 간염 바이러스의 펩타이드 항원을 함유하는 리포좀 | |
KR100189701B1 (ko) | B형 간염 바이러스의 x 단밸직 유래의 펩타이드 항원을 함유하는 리포좀 | |
CO4180620A1 (es) | Proceso para preparar formulaciones solidas que contienen tensioactivos de oxido de amina, que comprende una sal so- luble en agua de acido maleico-oxido de amina | |
JPH0292996A (ja) | アジュバントおよび脂質を含む複合体 | |
MXPA99009052A (en) | Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170401 |